{
  "CR_effector_expansion": {
    "description": "Massive expansion of effector cells during viral clearance",
    "mechanism": "Immune reactivation for HBV elimination",
    "clusters": [
      "9",
      "14",
      "8",
      "5"
    ],
    "evidence": "Log2_OR = -4.5 ~ -6.9 (IT vs others), KEGG autoimmune pathways"
  },
  "IT_monocyte_expansion": {
    "description": "Tolerogenic monocyte accumulation in IT phase",
    "mechanism": "Immunosuppressive environment maintenance",
    "clusters": [
      "20"
    ],
    "evidence": "Log2_OR = +2.50, IT = 2.21% vs Others = 0.40%"
  },
  "CR_metabolic_shift": {
    "description": "OXPHOS elevation in CR-specific CD4+ T cells",
    "mechanism": "High energy demand for effector function",
    "clusters": [
      "9"
    ],
    "evidence": "KEGG: Oxidative phosphorylation enriched"
  },
  "CR_autoimmune_response": {
    "description": "Strong autoimmune signatures during viral clearance",
    "mechanism": "Collateral immune activation for HBV elimination",
    "clusters": [
      "14"
    ],
    "evidence": "KEGG: GVHD, T1D, thyroiditis, allograft rejection"
  },
  "NK_dynamics": {
    "description": "NK cell redistribution across disease stages",
    "mechanism": "HBsAg-mediated IL-15R\u03b2/mTOR suppression in IT",
    "clusters": [
      "6",
      "10",
      "11",
      "18"
    ],
    "evidence": "Stage-dependent NK proportion changes"
  }
}